Methodological Consideration for Clinical Development of Bevacizumab Biosimilar Candidate

Kambiz Novin; Nafiseh Mortazavi

(Under development)

Reports of Radiotherapy and Oncology (RRO) is an international, specialized, peer-reviewed journal in all areas of oncology. The journal welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence in all fields of cancer, and will publish original articles in basic and applied research, case reports, case series, critical reviews, surveys, opinions, commentaries, and essays.

The Journal is currently under development and does not accpt any submissions at this website.

Methodological Consideration for Clinical Development of Bevacizumab Biosimilar Candidate

Kambiz Novin Department of Radiotherapy and Oncology, Haft-e-Tir Hospital, Faculty of Medicine, Iran University of Medical Sciences
Nafiseh Mortazavi

Keywords: Biosimilar Bevacizumab

Abstract

No Abstract

PDF(FULL TEXT)

Published

2019-03-17

How to Cite

Novin, K., & Mortazavi, N. (2019). Methodological Consideration for Clinical Development of Bevacizumab Biosimilar Candidate. Reports of Radiotherapy and Oncology, 5(1), 1-2. Retrieved from http://waocp.com/journal/index.php/Reports-of-Radiotherapy-and-Onco/article/view/2319

Download Citation

Issue

Vol 5 No 1 (2018)

Section

Articles